Segregational fidelity of chromosomes in human thyroid tumour cells

Chromosoma

Volumn 107, Issue 6-7, 1998, Pages 491-497

  Parry, E M ^a   Ulucan, H ^a   Wyllie, F S ^b   Wynford Thomas, D ^b   Parry, J M ^a  

^a SWANSEA UNIVERSITY   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

CANCER CELL CULTURE; CELL GROWTH; CHROMOSOME; CHROMOSOME LOSS; CHROMOSOME NUMBER; CHROMOSOME REARRANGEMENT; CHROMOSOME SEGREGATION; CONFERENCE PAPER; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; MITOSIS; POLYPLOIDY; THYROID CELL;

CHROMOSOME SEGREGATION; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 9; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; METAPHASE; POLYPLOIDY; THYROID NEOPLASMS; TRANSLOCATION, GENETIC; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032434108     PISSN: 00095915     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004120050334     Document Type: Conference Paper

References (27)

1. Agarwal AL, Agarwal A, Taylor WR, Stark GR (1995) p53 controls both the G2/M and the Gl cell cycle check-points and mediates reversible growth arrest in human fibroblastss. Proc Natl Acad Sci USA 92:8493-8497
2. Carder P, Wyllie AH, Purdie CA, Morris RG, White S, Piris J, Bird CC (1993) Stabilised p53 facilitates aneuploid clonal divergence in colorectal cancer. Oncogene 8:1397-1401
3. Cross MS, Sanchez CA, Morgan CA, Schimke MK, Ramel S, Idzersa RL, Raskind WH, Reid BJ (1995) A p53-dependent mouse spindle checkpoint. Science 267:1353-1356
4. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer E, Kinzer KW, Vogelstein B (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825
5. Elledge SJ (1996) Cell cycle checkpoints: preventing an identity crisis. Science 274:1664-1672
6. Gorbsky GJ (1997) Cell cycle checkpoints: arresting progress in mitosis. BioEssays 19:193-197
7. Gottlieb TM, Oren M (1996) p53 in growth and neoplasia. Biochim Biophys Acta 1287:77-102
8. Harper JW, Adami GR, Wei K, Keyomarsi K, Elledge SJ (1993) The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816
9. Harvey M, Sands AT, Weiss RS, Hegi ME, Wiseman RW, Pantazis P, Giovanella BC, Tainsky MA, Bradley A, Donehower LA (1993) In vitro growth characteristics of embryo fibroblasts isolated from p53 deficient mice. Oncogene 8:2457-2467
10. Hollstein M, Shomer B, Greenblatt M, Soussi T, Hovig E, Montesano R, Harris CC (1996) Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation. Nucleic Acids Res 24:141-146
11. Hoyt MA, Totis L, Roberts BT (1991) S. cerevisiae genes required for cell cycle arrest in response to loss of microtubule function. Cell 66:507-517
12. Li R, Murray AW (1991) Feedback control of mitosis in budding yeast. Cell 66:519-531
13. Li X, Nicklas RB (1995) Mitotic forces control a cell cycle checkpoint. Nature 373:630-632
14. Metz T, Harris AW, Adams JM (1995) Absence of p53 allows direct immortalization of hematopoietic cells by the myc and raf oncogenes. Cell 82:29-36
15. Michalovitz D, Halevy O, Oren M (1990) Conditional inhibition of transformation and of cell proliferation by a temperature sensitive mutant of p53. Cell 62:671-680
16. Minn AJ, Boise LH, Thompson CB (1996) Expression of Bcl-xl and loss of p53 can cooperate to overcome a cell cycle checkpoint induced by mitotic spindle damage. Genes Dev 10:2621-2631
17. Minshull J, Sun H, Tonks NK, Murray AW (1994) A MAP kinase-dependent spindle assembly checkpoint in Xenopus egg extracts. Cell 79:475-486
18. Ried T, Knutzen R, Steinbeck R, Blegen H, Schrock E, Heselmeyer K, Dumanoir S, Auer G (1996) Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors. Genes Chromosom Cancer 15:234-245
19. Rieder CL, Cole RW, Khodjakov A, Sluder G (1995) The checkpoint delaying anaphase in response to chromosome monoorientation is mediated by an inhibitory signal produced by unattached kinetochores. J Cell Biol 130:941-948
20. Shackney SE, Smith CA, Miller BW, Burholt DR, Murtha K, Giles HR, Ketterer DM, Pollice AA (1989) Model for the genetic evolution of human solid tumors. Cancer Res 49:3344-3354
21. Sherwood SW, Sheridan JP, Schimke RT (1994) Induction of apoptosis by the antitubulin drug colcemid - relationship of mitotic checkpoint control to the induction of apoptosis in Hela S3 cells. Exp Cell Res 215:373-379
22. Vikhanskaya F, Erba E, Dincalci M, Broggini M (1994) Introduction of wild type p53 in a human ovarian cancer cell line not expressing endogenous p53. Nucleic Acids Res 22:1012-1017
23. Wahl GM, Linke SP, Paulson TG, Huang LC (1997) Maintaining genetic stability through TP53 mediated checkpoint control. Cancer Surv 29:183-219
24. Wang Y, Prives C (1995) Increased and altered DNA binding of human p53 by S and G2/M but not G1 cyclin dependent kinases. Nature 376:88-91
25. Wyllie FS, Haughton MF, Blaydes JP, Schlumberger M, Wynford-Thomas D (1995) Evasion of p53-mediated growth control occurs by three alternative mechanisms in transformed thyroid epithelial cells. Oncogene 10:49-59
26. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D (1993) p21 is a universal inhibitor of cyclin kinases. Nature 366:701-704
27. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M (1991) Wild type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 352:345-347